Evidence map›Paper›PMID 29396849›Full record

ArticleClinical genetics2018

SAAMP 2.0: An algorithm to predict genotype-phenotype correlation of lysosomal storage diseases.

L Ou, M J Przybilla, C B Whitley

Abstract read
In one paragraph

Article in Clinical genetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Chitotriosidase as a biomarker for gangliosidoses.Molecular genetics and metabolism reports · 2021
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

L OuDepartment of Pediatrics, Gene Therapy Center, Minneapolis, Minnesota, USA.ORCID 0000-0002-7743-5649
M J PrzybillaDepartment of Genetics, Cell Biology and Development, University of Minnesota, Minneapolis, Minnesota.
C B WhitleyDepartment of Pediatrics, Gene Therapy Center, Minneapolis, Minnesota, USA.
University of Minnesota · USGene Therapy Laboratory · FR

Funding

Training & EducationU54NS065768 · NINDS · UNIVERSITY OF MINNESOTA · PI WHITLEY, CHESTER B. · 2009 to 2024
$17.7M
THERAPY FOR HYPERAMMONEMIA WITH GENETICALLY ENGINEERED BACTERIAP01HD032652 · NICHD · UNIVERSITY OF MINNESOTA TWIN CITIES · PI WHITLEY, CHESTER B. · 1995 to 2016
$14.5M
NICHD NIH HHS P01 HD032652NINDS NIH HHS U54 NS065768
6 · The paper itself

Abstract

Lysosomal storage diseases (LSDs) are a group of genetic disorders, resulting from deficiencies of lysosomal enzyme. Genotype-phenotype correlation is essential for timely and proper treatment allocation. Recently, by integrating prediction outcomes of 7 bioinformatics tools, we developed a SAAMP algorithm to predict the impact of individual amino-acid substitution. To optimize this approach, we evaluated the performance of these bioinformatics tools in a broad array of genes. PolyPhen and PROVEAN had the best performances, while SNP&GOs, PANTHER and I-Mutant had the worst performances. Therefore, SAAMP 2.0 was developed by excluding 3 tools with worst performance, yielding a sensitivity of 94% and a specificity of 90%. To generalize the guideline to proteins without known structures, we built the three-dimensional model of iduronate-2-sulfatase by homology modeling. Further, we investigated the phenotype severity of known disease-causing mutations of the GLB1 gene, which lead to 2 LSDs (GM1 gangliosidosis and Morquio disease type B). Based on the previous literature and structural analysis, we associated these mutations with disease subtypes and proposed a theory to explain the complicated genotype-phenotype correlation. Collectively, an updated guideline for phenotype prediction with SAAMP 2.0 was proposed, which will provide essential information for early diagnosis and proper treatment allocation, and they may be generalized to many monogenic diseases.

Indexed as

Genetic Association StudiesAlgorithmsAmino Acid Substitutionbeta-GalactosidaseComputational BiologyGangliosidosis, GM1Genetic Predisposition to DiseaseGenotypeHumansIduronate SulfataseLysosomal Storage DiseasesMucopolysaccharidosis IVMutant ProteinsMutationProtein Conformationbeta-GalactosidaseGLB1 protein, humanIduronate SulfataseMutant Proteinsgenotype-phenotype correlationGM1 gangliosidosishomology modelingin silicolysosomal storage diseaseMorquio syndrome

Identifiers

PMID29396849
PMCPMC5899622
OpenAlexW2801519819

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.